ANI Pharmaceuticals Inc
Închisă
SectorSănătate
82.22 -0.36
Rezumat
Modificarea prețului
24h
Minim
82.04
Maxim
83.9
Venit | -61K 27M |
|---|---|
Vânzări | -9.6M 237M |
P/E Medie Sector | 20.609 50.958 |
EPS | 1.68 |
Marjă de profit | 11.551 |
Angajați | 970 |
EBITDA | -20M 57M |
Recomandări | Puternic Cumpărare |
|---|---|
Prognoză pe 12 luni | +37.81% upside |
Următoarele câștiguri | 7 aug. 2026 |
|---|
Capitalizare de piață | -41M 1.8B |
|---|---|
Deschiderea anterioară | 82.58 |
Închiderea anterioară | 82.22 |
Sentimentul știrilor
By Acuity
50%
50%
146 / 342 Clasament în Healthcare
ANI Pharmaceuticals Inc Grafic
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
Despre ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.